CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
33.80 0.21(0.63%) NAV as on 19 Jun 2026
0.36 % 1 M
14.15 % 1 Y
22.36 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 31 Mar, 2026
age-icon Age :

6 yrs 11 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

950.31 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.16

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 3.17 %
Equity 96.83 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.42 %
Apollo Hospitals Enterprise Ltd.7.31 %
Torrent Pharmaceuticals Ltd.4.75 %
JB Chemicals & Pharmaceuticals...4.73 %
Aurobindo Pharma Ltd.4.37 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.07
Hospital & Healthcare Services20.09
Business Support1.01
Chemicals0.65
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 858.87
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.800.21(0.63%)NAV As on 19 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.14.15%1Y22.36%3Y13.05%5Y19.16%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.760.14(0.34%)NAV As on 19 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.8.95%1Y25.61%3Y15.79%5Y19.72%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity476.633.15(0.67%)NAV As on 19 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.14.65%1Y23.76%3Y16.30%5Y16.12%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.540.35(0.82%)NAV As on 19 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.14.88%1Y23.58%3Y14.54%5Y19.92%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.740.12(0.38%)NAV As on 19 Jun, 202628-Dec-2015Inception Date1,386.99AUM In Cr.8.28%1Y21.38%3Y13.76%5Y11.65%Since Inception